BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 23272159)

  • 1. Polysaccharide from Lentinus edodes inhibits the immunosuppressive function of myeloid-derived suppressor cells.
    Wu H; Tao N; Liu X; Li X; Tang J; Ma C; Xu X; Shao H; Hou B; Wang H; Qin Z
    PLoS One; 2012; 7(12):e51751. PubMed ID: 23272159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MPSSS impairs the immunosuppressive function of cancer-associated fibroblasts via the TLR4-NF-κB pathway.
    Xu Y; Ma J; Zheng Q; Wang Y; Hu M; Ma F; Qin Z; Lei N; Tao N
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30992392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polysaccharide Agaricus blazei Murill stimulates myeloid derived suppressor cell differentiation from M2 to M1 type, which mediates inhibition of tumour immune-evasion via the Toll-like receptor 2 pathway.
    Liu Y; Zhang L; Zhu X; Wang Y; Liu W; Gong W
    Immunology; 2015 Nov; 146(3):379-91. PubMed ID: 26194418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganoderma lucidum polysaccharide (GLP) enhances antitumor immune response by regulating differentiation and inhibition of MDSCs via a CARD9-NF-κB-IDO pathway.
    Wang Y; Fan X; Wu X
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32530032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of Myd88 signaling induces antitumor effects by skewing the immunosuppressive function of myeloid-derived suppressor cells.
    Hong EH; Chang SY; Lee BR; Kim YS; Lee JM; Kang CY; Kweon MN; Ko HJ
    Int J Cancer; 2013 Jun; 132(12):2839-48. PubMed ID: 23184679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics reveals the function reverse of MPSSS-treated prostate cancer-associated fibroblasts to suppress PC-3 cell viability via the FoxO pathway.
    Zhang T; Chen X; Sun L; Guo X; Cai T; Wang J; Zeng Y; Ma J; Ding X; Xie Z; Niu L; Zhang M; Tao N; Yang F
    Cancer Med; 2021 Apr; 10(7):2509-2522. PubMed ID: 33704935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Glucan enhances antitumor immune responses by regulating differentiation and function of monocytic myeloid-derived suppressor cells.
    Tian J; Ma J; Ma K; Guo H; Baidoo SE; Zhang Y; Yan J; Lu L; Xu H; Wang S
    Eur J Immunol; 2013 May; 43(5):1220-30. PubMed ID: 23424024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A polysaccharide from Lentinus edodes inhibits human colon cancer cell proliferation and suppresses tumor growth in athymic nude mice.
    Wang J; Li W; Huang X; Liu Y; Li Q; Zheng Z; Wang K
    Oncotarget; 2017 Jan; 8(1):610-623. PubMed ID: 27888812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers.
    Kodumudi KN; Woan K; Gilvary DL; Sahakian E; Wei S; Djeu JY
    Clin Cancer Res; 2010 Sep; 16(18):4583-94. PubMed ID: 20702612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans.
    Görgün GT; Whitehill G; Anderson JL; Hideshima T; Maguire C; Laubach J; Raje N; Munshi NC; Richardson PG; Anderson KC
    Blood; 2013 Apr; 121(15):2975-87. PubMed ID: 23321256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic targeting of myeloid-derived suppressor cells involves a novel mechanism mediated by clusterin.
    Zhou J; Donatelli SS; Gilvary DL; Tejera MM; Eksioglu EA; Chen X; Coppola D; Wei S; Djeu JY
    Sci Rep; 2016 Jul; 6():29521. PubMed ID: 27405665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of PPARγ in myeloid-derived suppressor cell-stimulated cancer cell proliferation and metastasis.
    Zhao T; Du H; Blum JS; Yan C
    Oncotarget; 2016 Jan; 7(2):1529-43. PubMed ID: 26625314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-glucan from Lentinus edodes inhibits breast cancer progression via the Nur77/HIF-1α axis.
    Zhang X; Li T; Liu S; Xu Y; Meng M; Li X; Lin Z; Wu Q; Xue Y; Pan Y; Alitongbieke G
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33245358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.
    Finke J; Ko J; Rini B; Rayman P; Ireland J; Cohen P
    Int Immunopharmacol; 2011 Jul; 11(7):856-61. PubMed ID: 21315783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin induces the differentiation of myeloid-derived suppressor cells and inhibits their interaction with cancer cells and related tumor growth.
    Tu SP; Jin H; Shi JD; Zhu LM; Suo Y; Lu G; Liu A; Wang TC; Yang CS
    Cancer Prev Res (Phila); 2012 Feb; 5(2):205-15. PubMed ID: 22030090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of chemical composition and cytotoxicity of water-soluble polysaccharides from Lentinus edodes fruiting bodies.
    Zheng Y; Hao M; Nan H; Jeff I; Zhou Y; Gao Y
    Pak J Pharm Sci; 2015 May; 28(3 Suppl):1069-74. PubMed ID: 26051725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury.
    Zhang C; Wang S; Li J; Zhang W; Zheng L; Yang C; Zhu T; Rong R
    Cell Death Dis; 2017 Mar; 8(3):e2695. PubMed ID: 28333137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical properties of polysaccharides from Lentinus edodes under high pressure cooking treatment and its enhanced anticancer effects.
    Li W; Wang J; Chen Z; Gao X; Chen Y; Xue Z; Guo Q; Ma Q; Chen H
    Int J Biol Macromol; 2018 Aug; 115():994-1001. PubMed ID: 29694839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-18 enhances immunosuppressive responses by promoting differentiation into monocytic myeloid-derived suppressor cells.
    Lim HX; Hong HJ; Cho D; Kim TS
    J Immunol; 2014 Dec; 193(11):5453-60. PubMed ID: 25362180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
    Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
    Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.